| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/07/2003 | CA2474007A1 Transgenic animals expressing prkag3 |
| 08/07/2003 | CA2474005A1 Prkag3 gene promoter and uses thereof |
| 08/07/2003 | CA2473994A1 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 08/07/2003 | CA2473990A1 Modulation of type ii.beta. phosphoinositide phosphate kinase |
| 08/07/2003 | CA2473810A1 Fgfr agonists |
| 08/07/2003 | CA2473806A1 Device and method for thermal cycling |
| 08/07/2003 | CA2473641A1 The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| 08/07/2003 | CA2473128A1 Genetic polymorphisms in the preprotachykinin gene |
| 08/07/2003 | CA2472153A1 Method and test kit for demonstrating genetic identity |
| 08/07/2003 | CA2471661A1 Molecular hepatotoxicology modeling |
| 08/07/2003 | CA2470195A1 Method and system for fusion and activation following nuclear transfer in reconstructed embryos |
| 08/07/2003 | CA2469738A1 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 08/07/2003 | CA2469571A1 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies |
| 08/07/2003 | CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses |
| 08/07/2003 | CA2464869A1 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 08/07/2003 | CA2464138A1 Methods of preventing and treating flavivirus infection in animals |
| 08/07/2003 | CA2463476A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/07/2003 | CA2438112A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells |
| 08/06/2003 | EP1333283A2 Method and reactor for conducting receptor-ligand association reactions |
| 08/06/2003 | EP1333280A1 Reagent and method for detecting biopolymers |
| 08/06/2003 | EP1333100A2 RET oligonucleotide microchip and method for detecting hereditary cancer employing same |
| 08/06/2003 | EP1333099A1 Method of searching for gene encoding nuclear transport protein |
| 08/06/2003 | EP1333096A1 Method to identify gene function using phage display screening |
| 08/06/2003 | EP1333095A1 Process for the reversible functional inactivation of the mismatch repair system |
| 08/06/2003 | EP1333094A2 Human telomerase catalytic subunit |
| 08/06/2003 | EP1333093A2 Human muscle nad: arginine adpribosyltransferase |
| 08/06/2003 | EP1333092A2 28 human secreted proteins |
| 08/06/2003 | EP1333091A1 Novel disease-associated gene and use thereof |
| 08/06/2003 | EP1333090A1 Prionprotein-specific aptamers |
| 08/06/2003 | EP1333089A1 Method of synthesizing single-stranded nucleic acid |
| 08/06/2003 | EP1333088A1 Paramyxovirus vectors for introducing foreign genes into skeletal muscle |
| 08/06/2003 | EP1333035A2 Growth differentiation factor-8 |
| 08/06/2003 | EP1333034A1 Use of angiotensin II analogs in tissue repair |
| 08/06/2003 | EP1332673A1 Method of controlling proliferation and differentiation of stem and progenitor cells |
| 08/06/2003 | EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 08/06/2003 | EP1332371A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 08/06/2003 | EP1332231A2 Methods for measuring drug resistance |
| 08/06/2003 | EP1332229A1 Method for screening agents capable of treating obesity |
| 08/06/2003 | EP1332227A2 Nucleic acid ligands to the prostate specific membrane antigen |
| 08/06/2003 | EP1332226A1 Method and apparatus for the in-situ preparation of macromolecules via uniform glow discharge plasma |
| 08/06/2003 | EP1332224A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung |
| 08/06/2003 | EP1332222A2 Metabolic rate shifts in fermentations expressing recombinant proteins |
| 08/06/2003 | EP1332220A2 Oligonucleotide - facilitated coalescence |
| 08/06/2003 | EP1332219A2 Use of the human lrp/mvp promotor for a vector that can be induced by therapy |
| 08/06/2003 | EP1332218A1 Differentiation-inducing substances |
| 08/06/2003 | EP1332217A2 Novel bacterial phytases and method for producing same |
| 08/06/2003 | EP1332216A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 08/06/2003 | EP1332215A2 Regulation of human secretin receptor-like gpcr |
| 08/06/2003 | EP1332214A2 32144, a human fatty acid amide hydrolase and uses thereof |
| 08/06/2003 | EP1332213A2 55063, a human nmda family member and uses thereof |
| 08/06/2003 | EP1332212A2 Proteins and nucleic acids encoding same |
| 08/06/2003 | EP1332211A2 Human cytokine receptor |
| 08/06/2003 | EP1332210A1 Use of mutagenic dna polymerase for producing random mutations |
| 08/06/2003 | EP1332209A2 Collections of repeat proteins comprising repeat modules |
| 08/06/2003 | EP1332207A2 Transformation systems for flavinogenic yeast |
| 08/06/2003 | EP1332206A1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 08/06/2003 | EP1332157A2 Prokineticin polypeptides, related compositions and methods |
| 08/06/2003 | EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 08/06/2003 | EP1332155A2 Immunization of dairy cattle with gapc protein against streptococcus infection |
| 08/06/2003 | EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 08/06/2003 | EP1332153A1 Human ect2 and methods of use |
| 08/06/2003 | EP1332150A1 Modified nucleosides and nucleotides and use thereof |
| 08/06/2003 | EP1332007A2 Modified carbon, silicon and germanium surfaces |
| 08/06/2003 | EP1331976A2 System and method for automated matched ion polynucleotide chromatography |
| 08/06/2003 | EP1331950A1 Methods and compositions for nucleic acid delivery |
| 08/06/2003 | EP1331949A2 Method for inducing apoptiosis |
| 08/06/2003 | EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation |
| 08/06/2003 | EP1331845A1 Barley with reduced ssii activity and starch containing products with a reduced amylopectin content |
| 08/06/2003 | EP1241933A4 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 08/06/2003 | EP1098664B1 Conjugates for treating inflammatory disorders and associated tissue damage |
| 08/06/2003 | EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds |
| 08/06/2003 | EP1017705B1 Rapid rna isolation procedure |
| 08/06/2003 | EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
| 08/06/2003 | EP0859959B1 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 08/06/2003 | EP0833943B1 Method for identifying secretory genes in helicobacter pylori |
| 08/06/2003 | EP0833940B1 Encoded reaction cassette |
| 08/06/2003 | EP0791076A4 Diagnostic method and kit for determining kell blood group genotype |
| 08/06/2003 | EP0788557A4 Rapid detection and identification of nucleic acid variants and pathogens |
| 08/06/2003 | EP0728018B1 New enzymes and prodrugs for ADEPT |
| 08/06/2003 | EP0695305B1 Method of forming oligonucleotides |
| 08/06/2003 | CN1434923A Conformational and topolodical protein regulation |
| 08/06/2003 | CN1434921A T2R taste receptors and genes encoding same |
| 08/06/2003 | CN1434875A Method of detecting neoplastic or non-neoplastic cells |
| 08/06/2003 | CN1434874A Detection of nucleic acids |
| 08/06/2003 | CN1434873A Method for selectively isolating nucleic acid |
| 08/06/2003 | CN1434872A Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 08/06/2003 | CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes |
| 08/06/2003 | CN1434869A Root-specific promoter |
| 08/06/2003 | CN1434868A Constructs for expression of plants |
| 08/06/2003 | CN1434867A Rice peroxidases with varius characteristics |
| 08/06/2003 | CN1434866A Rice-origin gibberellin 3beta-hydroxylase genes and utilization thereof |
| 08/06/2003 | CN1434865A Regulation effect of conjugated frame transport protein ABC1 |
| 08/06/2003 | CN1434864A Method of enhancing immune responses to herpes simplex virus vaccine |
| 08/06/2003 | CN1434863A Mutated BMP1B receptor as regulator of ovularion rate |
| 08/06/2003 | CN1434862A Improvement of nucleic acid vaccination |
| 08/06/2003 | CN1434861A Bacterial isolates of genus kiebsiella, and isomaltulose synthase gene isolated therefrom |
| 08/06/2003 | CN1434860A Process for producing L-amino acid and novel gene |
| 08/06/2003 | CN1434832A DNA for encoding the RGI polypeptide |
| 08/06/2003 | CN1434831A Improvments in or relating to immune responses to HIV |
| 08/06/2003 | CN1434746A Container for nucleic acid analysis |